MINDLAX REVOLUTIONIZES SLEEP SOLUTIONS WITH VIBROACOUSTIC SLEEPING MAT
The MindLax Sleeping Mat uses tactile-aural mechanisms that trigger the body's natural processes to induce relaxation and aid better sleep COLORADO SPRINGS, Colo., Feb. 21, 2023 /PRNewswire/ -- MindLax, the leading innovator in natural sleep and relaxation products and maker of the MindLax Sleeping Mat sleep solution system, today announces the availability of their Sleeping Mat on Kickstarter. ...
Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson’s disease
Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/ -- LISCure Biosciences Inc., a clinical-stage biotech developing advanced microbiome technology with precision targets, announced a multi-year strategic R&D collaboration with Celltrion to identify novel microbiome therapy for Parkinson's disease....
Angel Yeast Announces Plans to Beef up Supply and Innovation Capabilities In Response to Increasing Global Yeast Demand
YICHANG, China, Feb. 20, 2023 /PRNewswire/ -- The rising demand for yeast-based products over the past few years heralds steady growth of the market in the future, which also poses new challenges that require manufacturers to catalyze innovation and ramp up production and technology development to meet the evolving needs of their customers....
Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio
Duoning obtained exclusive license from BioAces for its cell analysis portfolio Through the partnership, the two companies will advance the development and commercialization of cell counters worldwide SHANGHAI, Feb. 20, 2023 /PRNewswire/ -- Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") entered into a strategic partnership with BioAces Shanghai Life Science Co., Ltd. ("BioAces") to obtain the exclusive global...
Daewoong Pharmaceutical Reaches Sales of KRW 1.16 Trillion in 2022, Fexuclue Leads The Highest Revenue
- Hitting a record high sale with business profits of KRW 106 billion and net profits of KRW 80.1 billion according to the accounting of 2022 - Not only stable positioning of Fexuclue but also achievement obtaining a permit of new medicine for Envlo SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/...
GC Biopharma Receives WHO Pre-Qualification for BARYCELA
YONGIN, South Korea, Feb. 20, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that the World Health Organization (WHO) has granted prequalification for BARYCELA, GC Biopharma's varicella vaccine. WHO prequalification decision has made BARYCELA now eligible for procurement by the United Nations agencies,...
Detailed Results from Telix’s ZIRCON Phase III Kidney Cancer Imaging Study Presented at ASCO GU
Trial met primary and secondary endpoints and confirmed favourable safety and tolerability profile, indicating TLX250-CDx has the potential to become a new clinical standard in the identification and characterisation of clear cell renal cell carcinoma (ccRCC): Primary endpoint met: Sensitivity of ≥84% and specificity of ≥84% in all three readers (86%...
Biosyngen has obtained FDA IND clearance of BRG01 for Phase I/II clinical trials against Nasopharyngeal Cancer
SINGAPORE, Feb. 17, 2023 /PRNewswire/ -- February 16th, 2023, Biosyngen Pte Ltd (hereinafter as "Biosyngen") was granted approval by US FDA for the company's IND application for BRG01 cell therapy, path the way for Phase I/II clinical trial. BRG01 is an autologous T cell therapy for relapsed/metastatic nasopharyngeal cancer (NPC) treatment. The principle of autologous T cell therapy is to...
Lunit to Establish Subsidiary in Europe to Accelerate Business Expansion
Lunit to establish new subsidiary, Lunit Europe Holdings, to expand sales network across Europe and strengthen global capabilities SEOUL, South Korea, Feb. 17, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global provider of AI-powered cancer solutions, today announced its decision to establish a new subsidiary, Lunit Europe Holdings, following a board...
Farrer Park Hospital launches clinical collaboration with ARC Hospitals
SINGAPORE, Feb. 17, 2023 /PRNewswire/ -- Farrer Park Hospital (FPH) has launched a clinical collaboration with Allegiant Regional Care (ARC) Hospitals to promote continuing medical education among specialists and physicians. The collaboration was officially launched at a joint surgical conference held at Cebu, Philippines on 11 February. The conference marked the start of the two healthcare providers' plans to...
